QUASAR is a Canadian-based company committed to providing advanced quality assurance solutions for medical physicists globally. The company, formerly known as Modus QA, has rebranded as IBA QUASAR as part of its integration into IBA Dosimetry, further strengthening its position in the industry. With a foundation built on industry-leading accuracy, QUASAR offers a comprehensive range of over 5,200 QUASARâ„¢ phantoms and software tools for various modalities, including MRI, IGRT, Motion, and IMRT. Additionally, their solutions encompass 3D dosimetry and optical CT scanners, which have been implemented in more than 3,400 premier treatment centers worldwide.
Founded in 2000, QUASAR operates within the manufacturing industry and boasts a strong dedication to precision and reliability. The company's unwavering commitment aims to provide medical physicists with the confidence that each patient receives optimal treatment. While specific details about the last investment and associated investors are not available, the company's focus on enhancing accuracy and innovative quality assurance signifies a promising opportunity for potential investors interested in the medical physics sector.
There is no investment information
No recent news or press coverage available for QUASAR.